8-Prenylnaringenin, inhibits estrogen receptor-α mediated cell growth and induces apoptosis in MCF-7 breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 107, Issue 3-5, 2007, Pages 140-148

  Brunelli, Elisa ^a   Minassi, Alberto ^a   Appendino, Giovanni ^a   Moro, Laura ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

8 Prenylnaringenin; Apoptosis; Breast cancer; Estrogen receptor; Signaling

Indexed keywords

8 PRENYLNARINGENIN; COUMESTROL; CYCLIN D1; DAIDZEIN; ESTROGEN RECEPTOR ALPHA; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NARINGENIN; PHYTOESTROGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BEER; BREAST CANCER; CANCER CELL; CELL GROWTH; ENZYME ACTIVATION; ESTROGEN ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; ONCOGENE SRC; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FLAVANONES; HUMANS; PROTO-ONCOGENE PROTEINS PP60(C-SRC);

EID: 34548587192     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.04.003     Document Type: Article

References (39)

1. Fenselau C., and Talalay P. Is oestrogenic activity present in hops?. Food Cosmet. Toxicol. 11 (1973) 597-603
2. Milligan S.R., Kalita J.C., Pocock V., Van De Kauter V., Stevens J.F., Deinzer M.L., Rong H., and De Keukeleire D. Identification of a potent phytoestrogen in hops (Humus lupulus L.) and beer. J. Clin. Endocrinol. Metabol. 85 (2000) 4912-4915
3. Schaefer O., Huempel M., Fritzemeier K.H., Bohlmann R., and Schleuning W.D. 8-Prenylnaringenin is a potent ERalpha selective phytoestrogen present in hops and beer. J. Ster. Biochem. Mol. Biol. 84 (2003) 359-360
4. Possemiers S., Heyerick A., Robbens V., De Keukeleire D., and Verstraete W. Activatioin of proestrognes from hops (Humus lupulus L.) by intestinal microbiota; Conversion of isoxanthohumol into 8-prenylnaringenin. J. Agric. Food Chem. 53 16 (2005) 6281-6288
5. Stevens J.F., and Page J.E. Xanthohumol and related prenylflavonoids from hops and beer: to your good health!. Phytochemistry 65 (2004) 1317-1330
6. Zierau O., Morrissey C., Watson R.W.G., Schwab P., Kolba S., Metz P., and Vollmer G. Antiandrogenic activity of the phytoestrogens naringenin, 6-(1, 1-dimethylallyl) naringenin and 8-prenylnaringenin. Planta Med. 69 (2003) 856-858
7. Ruh M.F., Zacharewski T., Connor K., Howell J., Chen I., and Safe S. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem. Pharmacol. 50 9 (1995) 1485-1493
8. Pepper M.S., Hazel S.J., Huempel M., and Schleuning W.D. 8-Prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo. J. Cell. Physiol. 199 (2004) 98-107
9. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E., and Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15 6 (1996) 1292-1300
10. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., Gong W., Beato M., and Auricchio F. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17 7 (1998) 2008-2018
11. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., De Falco A., Lombardi M., Fiorentino R., Varricchio L., Barone M.V., and Auricchio F. PI3-kinase in concert with Src promotes the S-phase entry of estradiol-stimulated MCF-7 cells. EMBO J. 20 21 (2001) 6050-6059
12. Castoria G., Migliaccio A., Di Domenico M., Lombardi M., De Falco A., Varricchio L., Bilancio A., Barone M.V., and Auricchio F. Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells. Mol. Cell Biol. 24 17 (2004) 7643-7653
13. Migliaccio A., Di Domenico M., Castoria G., Nanayakkara M., Lombardi M., De Falco A., Bilancio A., Varricchio L., Ciociola A., and Auricchio F. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Cancer Res. 65 22 (2005) 10585-10593
14. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19 8 (2005) 1951-1959 (Review)
15. Carpenter C.L., and Cantley L.C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8 2 (1996) 153-158 (Review)
16. Di Domenico M., Castoria G., Bilancio A., Migliaccio A., and Auricchio F. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res. 56 19 (1996) 4516-4521
17. Franke T.F., Kaplan D.R., and Cantley L.C. PI3K: downstream AKTion blocks apoptosis. Cell 88 4 (1997) 435-437 (Review)
18. Cabodi S., Moro L., Baj G., Smeriglio M., Di Stefano P., Gippone S., Surico N., Silengo L., Turco E., Tarone G., and Defilippi P. p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. J. Cell Sci. 117 Pt 8 (2004) 1603-1611
19. Anstead G.M., Carlson K.E., and Katzenellenbogen J.A. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62 3 (1997) 268-303 (Review)
20. Blair R.M., Fang H., Branham W.S., Hass B.S., Dial S.L., Moland C.L., Tong W., Shi L., Perkins R., and Sheehan D.M. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci. 54 1 (2000) 138-153
21. Sohoni P., and Sumpter J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158 3 (1998) 327-339
22. Akingbemi B.T., and Hardy M.P. Oestrogenic and antiandrogenic chemicals in the environment: effects on male reproductive health. Ann. Med. 33 6 (2001) 391-403 (Review)
23. Cassidy A., and Milligan S. How significant are environmental estrogens to women?. Climacteric 1 3 (1998) 229-242
24. Ashby J. Increasing the sensitivity of the rodent uterotrophic assay to estrogens, with particular reference to bisphenol A. Environ. Health Perspect. 109 11 (2001) 1091-1094 (Review)
25. Matsumura A., Ghosh A., Pope G.S., and Darbre P.D. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 94 (2005) 431-443
26. Beato M., Herrlich P., and Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 15 83(6) (1995) 851-857 (Review)
27. Mangelsdorf D.J., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
28. Parker M.G., and White R. Nuclear receptors spring into action. Nature Struct. Biol. 3 (1996) 113-115
29. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20 (1999) 321-344
30. Wehling M. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59 (1997) 365-393
31. Revelli A., Massobrio M., and Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocr. Rev. 19 (1998) 3-17
32. McEwen B.S., and Alves S.E. Estrogen actions in the central nervous system. Endocr. Rev. 20 (1999) 279-307
33. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., Barone M.V., Ametrano D., Zannini M.S., Abbondanza C., and Auricchio F. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 19 20 (2000) 5406-5417
34. Castoria G., Barone M.V., Di Domenico M., Bilancio A., Ametrano D., Migliaccio A., and Auricchio F. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18 9 (1999) 2500-2510
35. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., and Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
36. Rameh L.E., and Cantley L.C. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274 (1999) 8347-8350
37. Marte B.M., and Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22 (1997) 355-358
38. Coffer P.J., Jin J., and Woodgett J.R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335 (1998) 1-13
39. Rad M., Humpel M., Schaefer O., Schoemaker R.C., Schleuning W.D., Cohen A.F., and Burggraaf J. Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br. J. Clin. Pharmacol. 62 3 (2006) 288-296